Internal Medicine, Pulmonary Disease · Fort Wayne, IN
NPI
1821040791
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
7916 W Jefferson Blvd
Fort Wayne, IN, 46804
Phone (260) 432-2297
Groups this clinician bills Medicare through
Medicare paid, 2024
$85K
1,481 services
Medicare patients, 2024
499
Average age 73
Drug cost, 2024
$4.2M
2,280 prescriptions
Company payments, 2025
$1,170
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Eustace S Fernandes was code 99214 (office e&m - established), 228 times for 154 patients. In total Eustace S Fernandes billed 1,481 services in 40 codes, and Medicare paid $85K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 228 | 154 | $87.39 | $20K |
| 99233 Hospital E&M - Subsequent | Facility | 195 | 91 | $87.87 | $17K |
| 94729 Pulmonary Function Testing | Facility | 92 | 92 | $6.30 | $580 |
| 94726 Pulmonary Function Testing | Facility | 91 | 91 | $8.53 | $776 |
| 94729 Pulmonary Function Testing | Office | 89 | 88 | $37.03 | $3,296 |
| 94726 Pulmonary Function Testing | Office | 89 | 88 | $36.74 | $3,270 |
| 94060 Pulmonary Function Testing | Facility | 87 | 86 | $7.09 | $616 |
| 99232 Hospital E&M - Subsequent | Facility | 83 | 51 | $51.67 | $4,288 |
| 99291 Critical Care E&M | Facility | 66 | 40 | $152.21 | $10K |
| 94060 Pulmonary Function Testing | Office | 54 | 54 | $25.58 | $1,381 |
| 94010 Pulmonary Function Testing | Office | 49 | 42 | $16.69 | $818 |
| 94010 Pulmonary Function Testing | Facility | 39 | 38 | $5.45 | $212 |
| 31624 Bronchoscopy | Facility | 33 | 30 | $37.83 | $1,248 |
| 99204 Office E&M - New | Office | 24 | 24 | $103.63 | $2,487 |
| 31623 Bronchoscopy | Facility | 23 | 23 | $2.45 | $56.41 |
By year: 2022 $91K for 1,494 services; 2023 $87K for 1,573 services; 2024 $85K for 1,481 services.
Medicare prescription drug claims, 2024
In 2024, the drug Eustace S Fernandes prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 345 prescriptions and refills. In total Eustace S Fernandes wrote 2,280 Medicare prescriptions that cost $4.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 345 | 536 | 93 | $337K |
| Azithromycin Generic | 234 | 425 | 77 | $3,441 |
| Prednisone Generic | 146 | 230 | 69 | $866 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 141 | 196 | 55 | $3,979 |
| Montelukast Sodium Generic | 137 | 345 | 48 | $1,163 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 121 | 173 | 33 | $108K |
| Breo Ellipta Fluticasone/Vilanterol | 102 | 150 | 29 | $59K |
| Methylprednisolone Generic | 63 | 63 | 49 | $390 |
| Trikafta Elexacaftor/Tezacaftor/Ivacaft | 60 | 60 | Under 11 | $1.6M |
| Dupixent Pen Dupilumab | 60 | 65 | Under 11 | $243K |
| Ofev Nintedanib Esylate | 56 | 56 | Under 11 | $689K |
| Famotidine Generic | 56 | 140 | 17 | $836 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 45 | 63 | Under 11 | $4,825 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 33 | 57 | Under 11 | $27K |
| Creon Lipase/Protease/Amylase | 33 | 34 | Under 11 | $127K |
Brand drugs: - claims; generic drugs: 1,150 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Eustace S Fernandes $1,170 ($1,170 in general payments such as food, travel and fees) from 11 companies. The largest payer was Intuitive Surgical, Inc. with $797.
| Company | Payments | Amount |
|---|---|---|
| Intuitive Surgical, Inc. ISRG | 5 | $797 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $132 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $46.52 |
| GlaxoSmithKline, LLC. GSK | 2 | $37.4 |
| Genzyme Corporation SNY | 2 | $34.9 |
| United Therapeutics Corporation UTHR | 1 | $22.63 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $21.84 |
| Insmed, Inc. INSM | 1 | $21.65 |
| Pfizer Inc. PFE | 1 | $19.26 |
| Pulmonx Corporation LUNG | 1 | $19.18 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.